Practical considerations when treating chronic hepatitis E in solid organ transplant recipients
Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
International journal of clinical pharmacy - 43(2021), 3 vom: 10. Juni, Seite 753-755 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Choi, David K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
49717AWG6K |
|---|
| Anmerkungen: |
Date Completed 15.10.2021 Date Revised 15.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11096-020-01195-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317375164 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317375164 | ||
| 003 | DE-627 | ||
| 005 | 20231225163131.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11096-020-01195-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317375164 | ||
| 035 | |a (NLM)33169803 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Choi, David K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Practical considerations when treating chronic hepatitis E in solid organ transplant recipients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.10.2021 | ||
| 500 | |a Date Revised 15.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Hepatitis E virus | |
| 650 | 4 | |a Liver transplant | |
| 650 | 4 | |a Ribavirin | |
| 650 | 4 | |a Transplant | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Ribavirin |2 NLM | |
| 650 | 7 | |a 49717AWG6K |2 NLM | |
| 700 | 1 | |a Martin, Michelle T |e verfasserin |4 aut | |
| 700 | 1 | |a Chacra, Wadih |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Koppe, Sean |e verfasserin |4 aut | |
| 700 | 1 | |a Landers, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Naveed, Ammara |e verfasserin |4 aut | |
| 700 | 1 | |a Mikolajczyk, Adam E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical pharmacy |d 2011 |g 43(2021), 3 vom: 10. Juni, Seite 753-755 |w (DE-627)NLM203361717 |x 2210-7711 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2021 |g number:3 |g day:10 |g month:06 |g pages:753-755 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11096-020-01195-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2021 |e 3 |b 10 |c 06 |h 753-755 | ||